What are the top disease areas for clinical drug trials?
Drug Discovery World
FEBRUARY 20, 2023
Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, according to a recent report by analytics company Phesi. The approval was based on results from the PROpel Phase III trial, however, the drug was rejected by UK regulator NICE because it requires expensive genetic testing.
Let's personalize your content